Abstract:The present work models plutonium (Pu) biokinetics in a female former nuclear worker. Her bioassay measurements are available at the US Transuranium and Uranium Registries. The worker was internally exposed to a plutonium-americium mixture via acute inhalation at a nuclear weapons facility. She was medically treated with injections of 1 g Ca-DTPA on days 0, 5, and 14 after the intake. Between days 0 and 20, fecal and urine samples were collected and analyzed for 239Pu and 241Am. Subsequently, she was followed up for bioassay monitoring over 14 y, with additional post-treatment urine samples collected and analyzed for 239Pu. The uniqueness of this dataset is due to the availability of: (1) both early and long-term bioassay data from a female with plutonium intake; (2) data on chelation therapy for a female; and (3) fecal measurement results. Chelation therapy with Ca- and/or Zn-salts of DTPA is known to aid in reducing the internal radiation dose by enhancing the excretion of plutonium and americium from the body. Such enhancement affects plutonium biokinetics in the human body, posing a challenge to the internal dose assessment. The current radiation dose assessment practice is to exclude the data affected by Ca-DTPA from the analysis. The present analysis is the first to explicitly model the chelation-affected bioassay data in a female by using a newly developed chelation model. Thus, the bioassay data collected during and after the Ca-DTPA administrations were used for biokinetic modeling and dose assessment. The Markov Chain Monte Carlo method was used to investigate model parameter uncertainty, based on the bioassay data and assumed prior probability distributions. A χ2/nData (number of data points) ≈ 1 was observed in this study, which indicates self-consistency of the data with the model. Results of this study show that the worker's 239Pu intake was 12 Bq, with a committed effective dose to the whole-body of 1.2 mSv and a committed equivalent dose to the bone surfaces, liver, and lungs of 37.8, 9.1, and 0.8 mSv, respectively. This study also discusses the worker's dose reduction due to chelation treatment.

Decontamination of Actinide-contaminated Injured Skin with Ca-DTPA Products Using an Ex Vivo Rat Skin Model

Decontamination of rat and human skin experimentally contaminated with 99mTc, 201Tl and 131I radionuclides using "Dermadecon" - a skin decontamination kit: an efficacy study

Synthesis, Characterization and Application of DTPA-Modified Chitosan Hydrogel Dressing for Early Decontamination of Radioactive Contamination in Wounds

Four-decade follow-up of a plutonium-contaminated puncture wound treated with Ca-DTPA

Medical management of victims contaminated with radionuclides after a "dirty bomb" attack

Ex vivo decrease in uranium diffusion through intact and excoriated pig ear skin by a calixarene nanoemulsion

Medical Long-term Follow-up and Biomarkers Change for a Patient with Internal Contamination Combined with Skin Contamination of Several Radioactive Nuclides

Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders

Using VARSKIN+v1.2 to estimate dose from direct skin contamination with radionuclides 223Ra, 212Pb and 225Ac; considerations for Nuclear Medicine staff and associated Personal Protective Equipment (PPE)

Modeling Plutonium Decorporation in a Female Nuclear Worker Treated with Ca-DTPA after Inhalation Intake

Ex vivo skin diffusion and decontamination studies of titanium dioxide nanoparticles

The Impact of Time on Decorporation Efficacy After a “Dirty Bomb” Attack Studied by Simulation

Explanation of Specification of Decontamination for Radionuclides Contaminated Human Wound and Skin

Development and Characterization of a Novel Hydrogel for the Decontaminating of Radionuclide-Contaminated Skin Wounds.

Emergency department management of patients internally contaminated with radioactive material

Literature Survey on Decorporation of Radionuclides from the Human Body

The influence of extracorporeal clearance techniques on elimination of radiocesium after internal contamination

Decontamination efficacy of soapy water and water washing following exposure of toxic chemicals on human skin

Medical Therapy of Patients Contaminated with Radioactive Cesium or Iodine

Bisphosphonate-Containing Supramolecular Hydrogels For Topical Decorporation Of Uranium-Contaminated Wounds In Mice

Skin decontamination of Carfentanil in vitro